News for 'FDA'

India can deliver COVID-19 vaccine swiftly and efficiently

India can deliver COVID-19 vaccine swiftly and efficiently

Rediff.com4 Jan 2021

'Rolling out the vaccine is not a major challenge in India.'

Ranbaxy may pay $1 bn to settle FDA fine

Ranbaxy may pay $1 bn to settle FDA fine

Rediff.com5 May 2011

Ranbaxy Laboratories and the US health regulator are reportedly negotiating a settlement.

FIR filed against Snapdeal CEO, directors

FIR filed against Snapdeal CEO, directors

Rediff.com1 May 2015

In April, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.

US eases travel recommendations on India as Covid cases fall

US eases travel recommendations on India as Covid cases fall

Rediff.com20 Jul 2021

When last month's advisory was issued, India was struggling with a second wave of the pandemic with more than 3,00,000 daily new coronavirus cases being reported.

Maharashtra asks Snapdeal to stop selling prescription drugs

Maharashtra asks Snapdeal to stop selling prescription drugs

Rediff.com18 Apr 2015

Flipkart, Amazon, too, under radar

Ranbaxy gets important breather

Ranbaxy gets important breather

Rediff.com11 Oct 2013

Ranbaxy's US factory, Ohm Laboratories, is learnt to have got a clean chit from the American regulator. This US facility was under surveillance of the Food and Drug Administration (FDA) since the end of 2012.

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Rediff.com10 Nov 2020

After discussion with the Food and Drug Administration (FDA), the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases, the statement said.

Glenmark gets US FDA nod to sell painkiller drug

Glenmark gets US FDA nod to sell painkiller drug

Rediff.com6 Dec 2010

Glenmark said it along with its US-based partner has got the US health regulator's nod to manufacture and market two oxycodone products, used for treating moderate to severe pain, in the American market. The company's US arm, Glenmark Generics Inc and Lehigh Valley Technologies (LVT) have received US Food and Drug Administration nod for Oxycodone immediate release capsules, the company said in a filing to the Bombay Stock Exchange.

Regulator finds procedural lapses at Wockhardt's US facility

Regulator finds procedural lapses at Wockhardt's US facility

Rediff.com3 Jun 2014

The FDA had imposed a ban on the company's Waluj plant in May.

UK regulator's import alert on Wockhardt

UK regulator's import alert on Wockhardt

Rediff.com6 Jul 2013

According to the chairman, there will be an annual loss of Rs 100 crore due to the MHRA alert on Waluj plant

Trump defends use of HCQ, says it works in early stages of COVID-19

Trump defends use of HCQ, says it works in early stages of COVID-19

Rediff.com29 Jul 2020

There is no evidence that the drug can fight the virus, and regulators warn it may cause heart problems.

Ranbaxy loses exclusivity on heartburn drug in US

Ranbaxy loses exclusivity on heartburn drug in US

Rediff.com28 Jan 2015

FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain

USFDA issues warning against Cadila Pharmaceuticals

USFDA issues warning against Cadila Pharmaceuticals

Rediff.com12 Nov 2014

The FDA issued the letter on October 15, and has given the company 15 days to respond.

Why so many Indian food product exports get rejected

Why so many Indian food product exports get rejected

Rediff.com13 Sep 2016

India consistently ranked among the top three countries whose products were rejected for import by the regulator.

US VP Mike Pence receives COVID-19 vaccine on camera

US VP Mike Pence receives COVID-19 vaccine on camera

Rediff.com18 Dec 2020

"Confidence in the vaccine is what brings us here this morning," the US vice-president said in remarks following his vaccination. "I didn't feel a thing. Well done."

Mumbai cops grill pharma boss over Remdesivir stock; BJP fumes

Mumbai cops grill pharma boss over Remdesivir stock; BJP fumes

Rediff.com18 Apr 2021

The Bharatiya Janata Party in Maharashtra objected to the pharma executive's grilling by Mumbai police, saying the Shiv Sena-led government in the state was playing politics amid the pandemic.

Suspected human hair in tablet cited in Ranbaxy ban

Suspected human hair in tablet cited in Ranbaxy ban

Rediff.com18 Sep 2013

Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.

Parle knocks on Bombay HC doors over Mango Bite

Parle knocks on Bombay HC doors over Mango Bite

Rediff.com17 Oct 2012

On Oct 14, the Maharashtra unit of FDA had ordered recall of entire stock of Kachha Mango Bite from the marketplace.

What lies ahead for Sun Pharma post Ranbaxy merger approval

What lies ahead for Sun Pharma post Ranbaxy merger approval

Rediff.com31 Mar 2015

Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.

Serum Institute seeks regular marketing approval for Covishield

Serum Institute seeks regular marketing approval for Covishield

Rediff.com25 Oct 2021

If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.

Engaged with US entities for procurement of vaccines: MEA

Engaged with US entities for procurement of vaccines: MEA

Rediff.com20 May 2021

India is engaged with American entities for procurement of COVID-19 vaccines from the United States and their possible manufacturing in the country subsequently, the Ministry of External Affairs said on Thursday.

Nestle to face more action over Maggi?

Nestle to face more action over Maggi?

Rediff.com21 May 2015

Fast Moving Consumer Goods major Nestle may face more action by the Uttar Pradesh Food Safety and Drug Administration, which is testing more batches of Maggi after ordering recall of a batch of about 2 lakh packs of the instant noodles due to higher than permitted levels of lead and a food additive.

USFDA raises concerns about Ranbaxy's Toansa plant

USFDA raises concerns about Ranbaxy's Toansa plant

Rediff.com13 Jan 2014

All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.

'US need to give more Covid vaccine doses to India'

'US need to give more Covid vaccine doses to India'

Rediff.com7 Aug 2021

The United States has so far allocated only 7.5 million doses of Covid vaccines to India, which is not enough, a top Indian-American Congressman said while urging the Biden Administration to do more.

Indian regulator also scans Ranbaxy

Indian regulator also scans Ranbaxy

Rediff.com20 Sep 2013

The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.

Fake drugs land Maharashtra company in dock

Fake drugs land Maharashtra company in dock

Rediff.com3 Oct 2013

Food and Drug Authority Ghana said in a statement that officials of Bliss GVS Pharma of India and Ghanaian drug maker Tobinco Pharmaceuticals have apologised to it for importing 'fake malaria medicine' to Ghana to treat malaria in children.

India may fully vaccinate all adults by April next year

India may fully vaccinate all adults by April next year

Rediff.com30 Sep 2021

With the maximum dose gap of four months for Covishield, a large part of the population would not even be eligible for the second dose by the end of this year, report Ruchika Chitravanshi and Ishaan Gera.

ICMR to conduct nationwide sero surveys on Covid spread

ICMR to conduct nationwide sero surveys on Covid spread

Rediff.com12 Jun 2021

The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.

US drug regulator finds Indian companies critically ill

US drug regulator finds Indian companies critically ill

Rediff.com24 Sep 2013

The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.

After Ranbaxy, US FDA turns the heat on Actavis

After Ranbaxy, US FDA turns the heat on Actavis

Rediff.com13 Oct 2008

The US Congressional committee, which is inquiring into the country's Food and Drug Administration's handling of drug-marketing approvals of India's leading drug-maker Ranbaxy, has extended its probe into similar permissions given to Iceland's Actavis.

Available now: A 'female Viagra', but it comes with a warning

Available now: A 'female Viagra', but it comes with a warning

Rediff.com19 Aug 2015

The first drug to treat low sexual desire in premenopausal women, dubbed "female Viagra", has been approved in the United States, but with a warning about potentially dangerous side effects such as severe low blood pressure and fainting.

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Rediff.com10 Mar 2014

The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.

Biden administration goes into mission mode to help India fight COVID-19

Biden administration goes into mission mode to help India fight COVID-19

Rediff.com27 Apr 2021

'We are in close touch with Indian officials at all levels. We are also closely coordinating with our allies, friends, and Quad partners about how we can collectively support India in its hour of need,' a senior Biden administration official told reporters

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

Ranbaxy gets US FDA nod for Cefadroxil dosage

Ranbaxy gets US FDA nod for Cefadroxil dosage

Rediff.com27 Mar 2003

Indian drugmaker Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to market an oral suspension form of Warner Chilcott's Duricef antibiotic, the Bombay Stock Exchange

Reddy's files with US FDA for generic Olanzapine

Reddy's files with US FDA for generic Olanzapine

Rediff.com11 Mar 2003

Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US

JB Chem files 1st ANDA, US FDA

JB Chem files 1st ANDA, US FDA

Rediff.com16 Jan 2003

JB Chemicals & Pharmaceuticals Ltd on Thursday announced the filing of its first Abbreviated New Drug Application with the United States Food and Drug Administration.

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

US FDA tightens screws on sale of diet supplements

US FDA tightens screws on sale of diet supplements

Rediff.com29 Jun 2007

The US Food and Drug Administration has tightened rules for selling dietary supplements in the US market, making compliance with current good manufacturing practices mandatory for manufacturers.

Wockhardt gets FDA nod to market painkillers in US

Wockhardt gets FDA nod to market painkillers in US

Rediff.com20 Mar 2007

Wockhardt Ltd said on Tuesday it has got US Food and Drug Administration's approval to market painkiller tablets containing a combination of Dextropropoxyphene napsylate and Acetaminophen in the US market.